Methods for Study of Carbohydrate Metabolism

  • Jay S. Skyler
Part of the The Springer Series in Behavioral Psychophysiology and Medicine book series (SSBP)


This chapter will consider issues involved in the study of carbohydrate metabolism and of diabetes mellitus and its complications. As will become apparent from this introductory section, the study of carbohydrate metabolism and of diabetes mellitus are important considerations for investigators interested in cardiovascular behavioral medicine.


Insulin Resistance Insulin Secretion Plasma Glucose Insulin Action Insulin Response 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Bolli, G. M., Dimitriadis, G. D., Pehling, G. B., Baker, B. A., Haymond, M. W., Cryer, P. E., & Gerich, J. E. (1984). Abnormal glucose counterregulation after subcutaneous insulin on insulin-dependent diabetes mellitus. New England Journal of Medicine, 310, 1706–1711.PubMedCrossRefGoogle Scholar
  2. Bolli, G. E., DeFeo, P., DeCosmo, S., Permeilo, G., Ventura, M. M., Massi-Benedetti, M., Santeusanio, F., Gerich, J. E., & Brunetti, P. (1984). A reliable and reproducible test for adequate glucose counterregulation on type I diabetes mellitus. Diabetes, 33, 732–737.PubMedCrossRefGoogle Scholar
  3. Brenner, B. E. (1985). Clinical significance of the elevated anion gap. American Journal of Medicine, 79, 289–296.PubMedCrossRefGoogle Scholar
  4. Bunn, H. F. (1981). Nonenzymatic glycosylation of protein: Relevance to diabetes. American Journal of Medicine, 70, 325–330.PubMedCrossRefGoogle Scholar
  5. Canili, G. F. (1971). Physiology of insulin in man. Diabetes, 20, 785–799.Google Scholar
  6. Cerasi, E., & Luft, R. (1977). Insulin secretion and the development of diabetes in the adult. Acta Medica Scandinavica Supplementum, 601, 111–148.Google Scholar
  7. Chan, S. J., Kwok, S. C. M., & Steiner, D. F. (1981). The biosynthesis of insulin: Some genetic and evolutionary aspects. Diabetes Care, 4, 4–10.PubMedGoogle Scholar
  8. Claraldi, T. P., Kolterman, O. G., Scarlett, J. A., & Olefsky, J. M. (1982). Role of glucose transport in the post-receptor defect of non-insulin-dependent diabetes mellitus. Diabetes, 31, 1016–1024.Google Scholar
  9. Clark, A. J. L., Bilous, R. W., Keen, W. L., & Keen, H. (1982). Capillary tubes for blood glucose sampling. Diabetologia, 23, 539–540.PubMedCrossRefGoogle Scholar
  10. Clark, L. C., & Lyons, C. (1962). Electrode systems for continuous monitoring in cardiovascular surgery. Annals of the New York Academy of Sciences, 102, 29–45.PubMedCrossRefGoogle Scholar
  11. Clarke, W. L., Lamer, J., & Pohl, S. L. (Eds.). (1986). Methods in diabetes research: Vol. II. Clinical methods. New York: Wiley.Google Scholar
  12. Colwell, J. A., Lopes-Virella, M. F., Winocour, P. D., & Halushka, P. V. (1988). New concepts about the pathogenesis of atherosclerosis in diabetes mellitus. In M. E. Levin & L. W. O’Neal (Eds.), The diabetic foot (4th ed., pp. 51–70). St. Louis: Mosby.Google Scholar
  13. Cryer, P. E. (1981). Glucose counterregulation in man. Diabetes, 30, 261–264.PubMedGoogle Scholar
  14. DCCT Research Group. (1987). Diabetes control and complications trial (DCCT): Results of feasibility study. Diabetes Care, 10, 1–19.CrossRefGoogle Scholar
  15. DeFronzo, R. A. (1985). Diabetes and the kidney: An update. In J. M. Olefsky & R. S. Sherwin (Eds.), Diabetes mellitus: Management and complications (pp. 159–222). Edinburgh: Churchill Livingstone.Google Scholar
  16. DeFronzo, R. A., Robin, J. D., & Andres, R. (1979). Glucose clamp technique: A method for quantifying insulin secretion and resistance. American Journal of Physiology, 6, E214–E223.Google Scholar
  17. DeFronzo, R. A., Jacot, E., Jequier, E., Maeder, E., Wahren, J., & Felber, J. P. (1981). The effect of insulin on the disposal of intravenous glucose: Results from indirect calorimetry and hepatic and femoral venous catheterization. Diabetes, 30, 1000–1007.PubMedGoogle Scholar
  18. DeFronzo, R. A., Simonson, D., & Ferrannini, E. (1982). Hepatic and peripheral insulin resistance: A common feature of type II (non-insulin-dependent) and type I (insulin-dependent) diabetes mellitus. Diabetologia, 23, 313–319.PubMedCrossRefGoogle Scholar
  19. Ewing, D. J., & Clarke, B. F. (1986). Diabetic autonomic neuropathy: Present insights and future prospects. Diabetes Care, 9, 648–665.PubMedGoogle Scholar
  20. Ewing, D. J., Campbell, I. W., & Clarke, B. F. (1980). The natural history of diabetic autonomic neuropathy. Quarterly Journal of Medicine, 49, 95–108.PubMedGoogle Scholar
  21. Faber, O. K., & Binder, C. (1977). C-peptide response to glucagon: A test for the residual beta-cell function in diabetes mellitus. Diabetes, 26, 605–610.PubMedCrossRefGoogle Scholar
  22. Finegood, D. T., Bergman, R. N., & Vranic, M. (1987). Estimation of endogenous glucose production during hyperinsulinemic-euglycemic glucose clamps. Diabetes, 36, 914–924.PubMedCrossRefGoogle Scholar
  23. Forman, B. H., Goldstein, P. S., & Genel, M. (1974). Management of juvenile diabetes mellitus: Usefulness of 24-hour fractional quantitative urine glucose. Pediatrics, 53, 257–263.PubMedGoogle Scholar
  24. Ginsberg, H., Kimmerling, G., Olefsky, J. M., & Reaven, G. M. (1975). Demonstration of insulin resistance in untreated adult onset diabetic subjects with fasting hyperglycemia. Journal of Clinical Investigation, 55, 451–461.CrossRefGoogle Scholar
  25. Goldberg, R. B. (1981). Lipid disorders in diabetes. Diabetes Care, 4, 561–572.PubMedCrossRefGoogle Scholar
  26. Goldstein, D. E., Little, R. R., Wiedmeyer, H. M., England, J. D., & McKenzie, E. M. (1986). Glycated hemoglobin: Methodologies and clinical applications. Clinical Chemistry (Winston-Salem, North Carolina), 32, B64–B70.Google Scholar
  27. Guilbault, G. (1982). Enzymatic glucose electrodes. Diabetes Care, 5, 181–183.PubMedCrossRefGoogle Scholar
  28. Harano, Y., Ohgaku, S., Hidake, H., Haneda, K., Kikkawa, R., Shigeta, Y., & Abe, H. (1977). Glucose, insulin and somatostatin infusion for the determination of insulin sensitivity. Journal of Clinical Endocrinology and Metabolism, 45, 1124–1127.PubMedCrossRefGoogle Scholar
  29. Heding, L. G. (1972). Determination of total serum insulin (IRI) in insulin-treated diabetic patients. Diabetologia, 8, 260–266.PubMedCrossRefGoogle Scholar
  30. Heding, L. G. (1975). Radioimmunological determination of human C-peptide in serum. Diabetologia, 11, 541–548.PubMedCrossRefGoogle Scholar
  31. Holman, R. R., & Turner, R. C. (1979). Maintenance of basal plasma glucose and insulin concentration in maturity-onset diabetes. Diabetes, 28, 1039–1057.CrossRefGoogle Scholar
  32. James, R. C., & Chase, G. R. (1974). Evaluation of some commonly used semiquantitative methods for urinary glucose and ketone determinations. Diabetes, 23, 474–479.PubMedGoogle Scholar
  33. Jarett, L., Kiechle, F. L., Parker, J. C., & Macauley, S. L. (1983). The chemical mediators of insulin action: Possible targets for post-receptor defects. American Journal of Medicine, 74(1A), 31–38.PubMedCrossRefGoogle Scholar
  34. Kahn, C. R. (1978). Insulin resistance, insulin insensitivity, and insulin unresponsiveness: A necessary distinction. Metabolism, 27, 1893–1902.PubMedCrossRefGoogle Scholar
  35. Kahn, C. R., Soll, A. H., Neville, D. M., Goldfine, I. D., Archer, J. A., Gorden, P., & Roth, J. (1975). The insulin receptor in obesity and other states of altered insulin sensitivity. In G. A. Bray (Ed.), Obesity in perspective (DHEW Publication No. NIH 75-708, pp. 301–311). Washington, DC: U.S. Government Printing Office.Google Scholar
  36. Kahn, C. R., Baird, K. L., Flier, J. S., Grunfeld, C., Harmon, J. T., Harrison, L. C., Karlsson, F. A., Kasuga, M., King, G. L., Lang, U.C., Podskainy, J. M., & Van Obberghen, E. (1981). Insulin receptors, receptor antibodies, and the mechanisms of insulin action. Recent Progress in Hormone Research, 37, 477–538.PubMedGoogle Scholar
  37. Kahn, C. R., White, M. F., Grigorescu, F., Takayama, S., Haring, H. U., & Crettaz, M. (1985). The insulin receptor protein kinase. In M. P. Czech (Ed.), Molecular basis of insulin action (pp. 67–94). New York: Plenum Press.CrossRefGoogle Scholar
  38. Karnieli, E., Hissin, P. J., Simpson, I. A., Salans, L. B., & Cushman, S.W. (1981). A possible mechanism of insulin resistance in the rat adipose cell in streptozotocin-induced diabetes mellitus. Journal of Clinical Investigation, 68, 811–814.PubMedCrossRefGoogle Scholar
  39. Keen, H., & Jarrett, J. (Eds.). (1982). Complications of diabetes (2nd ed.). London: Arnold.Google Scholar
  40. Kemmer, F. W., Bisping, R., Steingruber, H. J., Baar, H., Hardtmann, F., Schlaghecke, R., & Berger, M. (1986). Psychological stress and metabolic control in patients with type I diabetes mellitus. New England Journal of Medicine, 314, 1078–1084.PubMedCrossRefGoogle Scholar
  41. Klein, R. (1985). Retinopathy and other ocular complications in diabetes. In J. M. Olefsky & R. S. Sherwin (Eds.), Diabetes mellitus: Management and complications (pp. 101–158). Edinburgh: Churchill Livingstone.Google Scholar
  42. Kohler, E. (1978). On materials for testing glucose in urine. Diabetes Care, 1, 61–64.CrossRefGoogle Scholar
  43. Kolterman, O. G., Insel, J., Saekow, M., & Olefsky, J. M. (1980). Mechanisms of insulin resistance in human obesity—Evidence for receptor and postreceptor defects. Journal of Clinical Investigation, 65, 1273–1284.CrossRefGoogle Scholar
  44. Kolterman, O. G., Gray, R. S., Griffin, J., Burstein, P., Insel, J., Scarlett, J. A., & Olefsky, J. M. (1981). Receptor and post-receptor defects contribute to insulin resistance in noninsulin dependent diabetes mellitus. Journal of Clinical Investigation, 68, 957–969.PubMedCrossRefGoogle Scholar
  45. Kuzuya, H., Blix, P. M., Horwitz, D. L., Steiner, D. F., & Rubenstein, A. H. (1977). Determination of free and total insulin and C-peptide in insulin treated diabetes. Diabetes, 26, 22–29.PubMedCrossRefGoogle Scholar
  46. Lacy, P. E. (1977). The physiology of insulin release. In B. W. Volk & K. F. Wellman (Eds.), The diabetic pancreas (pp. 211–230). New York: Plenum Press.CrossRefGoogle Scholar
  47. Larner, J. (1983). Mediators of postreceptor action of insulin. American Journal of Medicine 74(1A), 38–51.PubMedCrossRefGoogle Scholar
  48. Lebovitz, H. E., & Feinglos, M. N. (1980). Therapy of insulin independent diabetes mellitus: General considerations. Metabolism, 29, 474–481.PubMedCrossRefGoogle Scholar
  49. Lebovitz, H. E., & Feinglos, M. N. (1986). Noninsulin-dependent diabetes mellitus. In P. O. Kohler (Ed.), Clinical endocrinology (pp. 574–602). New York: Wiley.Google Scholar
  50. Lebovitz, H. E., Feinglos, M. N., Bucholtz, H. K., & Lebovitz, F. L. (1977). Potentiation of insulin action: A probable mechanism for the anti-diabetic action of sulfonylurea drugs. Journal of Clinical Endocrinology and Metabolism, 45, 601–604.PubMedCrossRefGoogle Scholar
  51. Lloyd, D. R., Nott, M., & Marples, J. (1985). Comparison of serum fructosamine with glycosylated serum protein (determined by affinity chromatography) for the assessment of diabetic control. Diabetic Medicine, 2, 474–478.PubMedCrossRefGoogle Scholar
  52. Ludvigsson, J., & Heding, L. G. (1976). C-peptide in children with diabetes mellitus. Diabetologia, 12, 627–630.PubMedCrossRefGoogle Scholar
  53. Ludvigsson, J., & Heding, L. G. (1977). C-peptide in diabetic children after stimulation of glucagon compared with fasting C-peptide levels in non-diabetic children. Acta Endo-crinologica, 85, 364–371.Google Scholar
  54. Ludvigsson, J., Heding, L. G., Larsson, Y., & Leander, E. (1977). C-peptide in juvenile diabetics beyond the postinitial remission period. Acta Paediatrica Scandinavica, 66, Ill-ISA.Google Scholar
  55. MacGillivray, M. H., Voorhees, M. L., Putnam, T. I., Li, P. K., Schaefer, P. A., & Brack, E. (1982). Hormone and metabolic profiles in children and adolescents with type I diabetes mellitus. Diabetes Care, 5 (Suppl. 1), 38–47.PubMedGoogle Scholar
  56. Mandarino, L. J., & Gerich, J. E. (1984). Prolonged sulfonylurea administration decreases insulin resistance and increases insulin secretion in non-insulin-dependent diabetes mellitus: Evidence for improved insulin action at a postreceptor site in hepatic as well as extrahepatic sites. Diabetes Care, 7 (Suppl. 1), 89–99.PubMedGoogle Scholar
  57. Massi-Benedetti, M., Burrin, J. M., Capaldo, B., & Alberti, K. G. M. M. (1981). A comparative study of the activity of biosynthetic human insulin and pork insulin using the glucose clamp technique in normal subjects. Diabetes Care, 4, 163–167.PubMedCrossRefGoogle Scholar
  58. McMillan, D. E., & Geevarghese, P. J. (1979). Dietary cyanide and tropical malnutrition diabetes. Diabetes Care, 2, 202–208.PubMedCrossRefGoogle Scholar
  59. Nathan, D. M., Singer, D. E., Hurxthal, K., & Goodson, J. D. (1984). The clinical information value of the glycosylated hemoglobin assay. New England Journal of Medicine, 310, 341–346.PubMedCrossRefGoogle Scholar
  60. National Diabetes Data Group. (1979). Classification of diabetes mellitus and other categories of glucose intolerance. Diabetes, 28, 1039–1057.Google Scholar
  61. National Diabetes Data Group. (1985). Diabetes in America (U.S. Public Health Service Publication No. 85-1468). Washington, DC: NIADDKD, NIH.Google Scholar
  62. Olefsky, J. M. (1976a). The insulin receptor: Its role in insulin resistance of obesity and diabetes. Diabetes, 25, 1154–1164.PubMedGoogle Scholar
  63. Olefsky, J. M. (1976b). Effects of fasting on insulin binding, glucose transport, and glucose oxidation in isolated rat adipocytes: Relationships between insulin receptors and insulin action. Journal of Clinical Investigation, 58, 1450–1460.PubMedCrossRefGoogle Scholar
  64. Olefsky, J. M. (1981). Insulin resistance and insulin action: An in vitro and in vivo perspective. Diabetes, 30, 148–162.PubMedGoogle Scholar
  65. Olefsky, J. M., Ciarali, T. P., & Kolterman, O. G. (1985). Mechanisms of insulin resistance in non-insulin-dependent (type II) diabetes. American Journal of Medicine, 79(3), 12–22.PubMedCrossRefGoogle Scholar
  66. Parving, H. H., Andersen, A. R., Smidt, U. M., Christiansen, J. S., Oxenboli, B., & Svendsen, P. A. (1983). Diabetic nephropathy and arterial hypertension. Diabetes, 32 (Suppl. 2), 83–87.PubMedGoogle Scholar
  67. Parving, H. H., Andersen, A. R., Smidt, U. M., Hommel, E., Mathiesen, E. R., & Svendsen, P. A. (1987). Effect of antihypertensive treatment on kidney function in diabetic nephropathy. British Medical Journal, 294, 1443–1447.PubMedCrossRefGoogle Scholar
  68. Pfeifer, M. A., Halter, J. B., Graf, R., & Porte, D. (1980). Potentiation of insulin secretion to nonglucose stimuli in normal man by tolbutamide. Diabetes, 29, 335–340.PubMedCrossRefGoogle Scholar
  69. Pfeifer, M. A., Halter, J. B., & Porte, D. (1981). Insulin secretion in diabetes mellitus. American Journal of Medicine, 70, 579–588.PubMedCrossRefGoogle Scholar
  70. Pfeifer, M. A., Halter, J. B., Judzewitsch, R. G., Beard, J. C., Best, J. D., Ward, W. K., & Porte, D. (1984). Acute and chronic effects of sulfonylurea drugs on pancreatic islet function in man. Diabetes Care, 7 (Suppl. 1), 25–34.PubMedCrossRefGoogle Scholar
  71. Pickup, J. C., Home, P. D., Bilous, R. W., Keen, H., & Alberti, K. G. M. M. (1981). Management of severely brittle diabetes by continuous subcutaneous and intramuscular insulin infusions: Evidence for a defect in subcutaneous insulin absorption. British Medical Journal, 282, 347–350.PubMedCrossRefGoogle Scholar
  72. Polansky, K., Frank, B., Pugh, W., Addis, A., Karrison, T., Meler, P., Tager, H., & Rubenstein, A. (1986). The limitations to and valid use of C-peptide as a marker of the secretion of insulin. Diabetes, 35, 379–386.CrossRefGoogle Scholar
  73. Porte, D., & Halter, J. B. (1982). The endocrine pancreas and diabetes mellitus. In R. H. Williams (Ed.), Textbook of endocrinology (6th ed., pp. 716–843). Philadelphia: Saunders.Google Scholar
  74. Porte, D., & Pupo, A. A. (1969). Insulin responses to glucose: Evidence for a two pool system in man. Journal of Clinical Investigation, 48, 2309–2319.PubMedCrossRefGoogle Scholar
  75. Porte, D., Pfeifer, M. A., Halter, J. B., Beard, J. C., Best, J. D., & Ward, W. K. (1982). Impaired B-cell function in noninsulin-dependent diabetes mellitus: The essential lesion? In J. S. Skyler (Ed.), Insulin update 1982 (pp. 1–23). Princeton: Excerpta Medica.Google Scholar
  76. Prince, M. J., Tsai, P., & Olefsky, J. M. (1981). Insulin binding, internalization, and insulin-receptor regulation in fibroblasts from type II noninsulin dependent diabetic subjects. Diabetes, 30, 596–600.PubMedCrossRefGoogle Scholar
  77. Raptis, S., Karalskos, C., Enzmann, F., Hatzidakis, D., Zoupas, C., Souvatzoglou, A., Diamantopoulos, E., & Moulopoulos, S. (1981). Biological activities of biosynthetic human insulin in healthy volunteers and insulin dependent diabetic patients monitored by the artificial endocrine pancreas. Diabetes Care, 4, 140–143.PubMedCrossRefGoogle Scholar
  78. Ratzmann, K. P., Besch, W., Witt, S., & Schulz, B. (1981). Evaluation of insulin resistance during inhibition of endogenous insulin and glucagon secretion by somatostatin in nonobese subjects with impaired glucose tolerance. Diabetologia, 21, 192–197.PubMedCrossRefGoogle Scholar
  79. Reaven, G. M. (1983). Insulin resistance in non-insulin dependent diabetes mellitus. Does it exist and can it be measured?. American Journal of Medicine, 74(1A), 3–17.PubMedCrossRefGoogle Scholar
  80. Reaven, G. M., & Miller, R. G. (1979). An attempt to define the nature of chemical diabetes using a multidimensional analysis. Diabetologia, 16, 17–24.PubMedCrossRefGoogle Scholar
  81. Reaven, G. M., Bernstein, R., Davids, B., Olefsky, J. M. (1976). Nonketotic diabetes mellitus: Insulin deficiency or insulin resistance?. American Journal of Medicine, 60, 80–88.PubMedCrossRefGoogle Scholar
  82. Reeves, M. L., Seigler, D. E., Ryan, E. A., & Skyler, J. S, (1982). Glycemic control in insulin-dependent diabetes mellitus: Comparison of outpatient intensified conventional therapy with continuous subcutaneous insulin infusion. American Journal of Medicine, 72, 673–680.PubMedCrossRefGoogle Scholar
  83. Reeves, W. B. (1983). Insulin antibody determination: Theoretical and practical consideration. Diabetologia, 24, 399–403.PubMedCrossRefGoogle Scholar
  84. Rizza, R. A., Mandarino, L. J., & Gerich, J. E. (1981a). Mechanism and significance of insulin resistance in noninsulin-dependent diabetes mellitus. Diabetes, 30, 990–995.PubMedCrossRefGoogle Scholar
  85. Rizza, R. A., Mandarino, L. J., & Gerich, J. E. (1981b). Mechanisms of insulin resistance in man. Assessment using the insulin dose-response curve in conjunction with insulin receptor binding. American Journal of Medicine, 70, 169–176.PubMedCrossRefGoogle Scholar
  86. Rosenbloom, A. L., & Malone, J. I. (1978). Recognition of impending ketoacidosis delayed by ketone reagent strip failure. Journal of the American Medical Association, 240, 2462–2464.PubMedCrossRefGoogle Scholar
  87. Roth, J. (1981). Insulin binding to its receptor: Is the receptor more important than the hormone?. Diabetes Care, 4, 27–32.PubMedCrossRefGoogle Scholar
  88. Rubenstein, A. H., Horwitz, D. L., & Steiner, D. F. (1975). Clinical significance of circulating proinsulin and C-peptide. In K. E. Sussman & R. J. S. Metz (Eds.), Diabetes mellitus (4th ed., pp. 9–14). New York: American Diabetes Association.Google Scholar
  89. Ryan, C. (1988). Neurobehavioral complications of type I diabetes. Examination of possible risk factors. Diabetes Care, 11, 86–93.PubMedCrossRefGoogle Scholar
  90. Schade, D. S., Eaton, R. P., Mitchell, W., & Ortega, T. (1980). Glucose and insulin response to high carbohydrate meals in normal and maturity onset diabetic subjects. Diabetes Care, 3, 242–244.PubMedCrossRefGoogle Scholar
  91. Service, F. J., & Nelson, R. L. (1980). Characteristics of glycemic instability. Diabetes Care, 3, 58–62.PubMedCrossRefGoogle Scholar
  92. Service, F. J., Molnar, G. D., & Taylor, W. F. (1972). Urine glucose analyses during continuous blood glucose monitoring. Journal of the American Medical Association, 222, 294–298.PubMedCrossRefGoogle Scholar
  93. Service, F. J., O’Brien, P. C., & Rizza, R. A. (1987). Measurements of glucose control. Diabetes Care, 10, 225–237.PubMedGoogle Scholar
  94. Shen, S. W., Reaven, G. M., & Farquhar, J. (1970). Comparison of impedance to insulin-mediated glucose uptake in normal subjects and in subjects with latent diabetes. Journal of Clinical Investigation, 49, 2151–2160.PubMedCrossRefGoogle Scholar
  95. Skyler, J. S. (1979). Complications of diabetes mellitus: Relationship to metabolic dysfunction. Diabetes Care, 2, 499–509.Google Scholar
  96. Skyler, J. S. (1982a). Nondiabetic melliturias. In B. N. Bro-doff & S. J. Bleicher (Eds.), Diabetes mellitus and obesity (pp. 407–413). Baltimore: Williams & Wilkins.Google Scholar
  97. Skyler, J. S. (1982b). On the pathogenesis and treatment of non-insulin-dependent diabetes mellitus. In J. S. Skyler (Ed.), Insulin update 1982 (pp. 247–259). Princeton: Excerpta Medica.Google Scholar
  98. Skyler, J. S. (1984). Non-insulin dependent diabetes mellitus—A clinical strategy. Diabetes Care, 7 (Suppl. 1), 118–129.PubMedGoogle Scholar
  99. Skyler, J. S. (1986). Insulin-dependent diabetes mellitus. In P. O. Kohler (Ed.), Clinical endocrinology (pp. 491–573). New York: Wiley.Google Scholar
  100. Skyler, J. S. (1987). Why control blood glucose?. Pediatric Annals, 16, 713–724.PubMedGoogle Scholar
  101. Skyler, J. S., & Rabinovitch, A. (1987). Etiology and pathogenesis of insulin-dependent diabetes mellitus. Pediatric Annals, 16, 682–692.PubMedGoogle Scholar
  102. Skyler, J. S., Reeves, M. L., Seigler, D. E., & Ryan, E. A. (1983). Self-monitoring of blood glucose and intensive conventional therapy: Comparison with continuous subcutaneous insulin infusion in insulin-dependent diabetes mellitus. In P. Brunetti, K. G. M. M. Alberti, A. M. Albisser, K. D. Hepp, & M. Massi-Benedetti (Eds.), Artificial systems for insulin delivery (pp. 329–338). New York: Raven Press.Google Scholar
  103. Small, M., Cohen, H. N., Beastall, G. H., & MacCuish, A. C. (1985). Comparison of oral glucose loading and intravenous glucagon injection as stimuli to C-peptide secretion in normal man. Diabetic Medicine, 2, 181–183.PubMedCrossRefGoogle Scholar
  104. Srikanta, S., Ganda, O. P., Eisenbarth, G. S., & Soeldner, J. S. (1983). Islet-cell antibodies and beta-cell function in monozygotic triplets and twins initially discordant for type I diabetes mellitus. New England Journal of Medicine, 308, 322–325.PubMedCrossRefGoogle Scholar
  105. Srikanta, S., Ganda, O. P., Jackson, R. A., Gleason, R. E., Kaldany, A., Garovoy, M. R., Milford, E. L., Carpenter, C. B., Soeldner, J. S., & Eisenbarth, G. S. (1983). Type I diabetes mellitus in monozygotic twins: Chronic progressive beta cell dysfunction. Annals of Internal Medicine, 99, 320–326.PubMedCrossRefGoogle Scholar
  106. Steiner, D. F. (1977). Insulin today. Banting Memorial Lecture. Diabetes, 26, 322–340.PubMedGoogle Scholar
  107. Surwit, R. S., & Feinglos, M. N. (1988). Stress and autonomic nervous system in type II diabetes. A hypothesis. Diabetes Care, 11, 83–85.PubMedGoogle Scholar
  108. Tattersal, R. B., & Fajans, S. S. (1975). A difference between the inheritance of classical juvenile-onset and maturity-onset type diabetes of young people. Diabetes, 24, 44–53.CrossRefGoogle Scholar
  109. Vardi, P., Dib, S. A., Tuttleman, M., Connelly, J. E., Grinbergs, M., Radizabeh, A., Riley, W. J., MacLaren, N. K., Eisenbarth, G. S., & Soeldner, J. S. (1987). Competitive insulin autoantibody assay. Prospective evaluation of subjects at high risk for development of type I diabetes mellitus. Diabetes, 36, 1286–1291.PubMedCrossRefGoogle Scholar
  110. Watkins, P. J. (Ed.). (1986). Long-term complications of diabetes. Clinics in Endocrinology and Metabolism, 75(4). London: Saunders.Google Scholar
  111. White, N. H., Skor, D. A., Cryer, P. E., Levandoski, L., Bier, D. M., & Santiago, J. V. (1983). Identification of type I diabetic patients at increased risk for hypoglycemia during intensive therapy. New England Journal of Medicine, 308, 485–491.PubMedCrossRefGoogle Scholar
  112. WHO Expert Committee on Diabetes Mellitus. (1980). Second Report. Technical Report Series 646. Geneva: WHO.Google Scholar
  113. Winter, W. E., MacLaren, N. K., Riley, W. J., Clarke, D. W., Kappy, M. S., & Spillar, R. P. (1987). Maturity-onset diabetes of youth in black americans. New England Journal of Medicine, 316, 282–285.CrossRefGoogle Scholar
  114. Woods, S. C., Smith, P. H., & Porte, D. (1981). The role of the nervous system in metabolic regulation and its effect on diabetes and obesity. In M. Brownlee (Ed.), Handbook of diabetes mellitus (Vol. 3, pp. 208–271). New York: Garland.Google Scholar
  115. Zatz, R., & Brenner, B. M. (1986). Pathogenesis of diabetic microanglopathy. The hemodynamic view. American Journal of Medicine, 80, 443–453.PubMedCrossRefGoogle Scholar
  116. Zimmet, P. (1979). Epidemiology of diabetes and its macrovascular manifestations in pacific populations: The medical effects of social progress. Diabetes Care, 2, 144–153.PubMedCrossRefGoogle Scholar
  117. Zimmet, P. (1982). Type 2 (non-insulin-dependent) diabetes— An epidemiological overview. Diabetologia, 22, 399–411.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1989

Authors and Affiliations

  • Jay S. Skyler
    • 1
  1. 1.Departments of Medicine, Pediatrics, and PsychologyUniversity of MiamiMiamiUSA

Personalised recommendations